Skip to content
Friday, February 3, 2023
Latest:
  • Philosophy, an ancient practice with modern appeal? The role of “big” questions in medical decision-making
  • Sensitive, rapid tests help to ID estrogen-disrupting chemicals in the environment
  • Why women with heart issues are undertreated and have worse outcomes than men
  • Breakthrough epigenetic study can improve the power to predict disease risk
  • When visible meets invisible: the importance of psychological screening and intervention in pediatric dermatology

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

proteogenomics

From The Labs 

Using proteogenomics to improve the treatment of squamous cell carcinoma

February 4, 2021February 4, 2021precision cancer treatment, proteogenomics, Research, squamous cell carcinoma

Integrating proteogenomics data of squamous cell carcinoma provides insights into genomic defects with implications for potential treatments.

Read more
From The Labs 

An unprecedented look at endometrial cancer

February 20, 2020February 20, 2020endometrial cancer, personalized medicine, proteogenomics, Research, uterine cancer

Which therapy will benefit this particular patient the most? Dr. Bing Zhang and his colleagues offer insights that might help physicians better answer this question

Read more
From The Labs 

Scientists get up close and personal with breast cancer

February 18, 2020February 18, 2020Breast Cancer, cancer diagnosis, ErbB2, HER2, proteogenomics, Research

“Patients die from cancer because, at a sufficiently fundamental level, we have not been able to work out what kind of cancer we are treating,”

Read more
From The Labs 

A comprehensive view of colon cancer opens new avenues for research

April 25, 2019April 25, 2019Colon Cancer, proteogenomics, Research

Analyzing both the entire set of genes and all the proteins produced by colon cancer tissues from patient samples has revealed a more comprehensive view

Read more
From The Labs 

An integrated approach to finding new treatments for breast cancer

December 11, 2018December 11, 2018DPYSL3, Metastasis, proteogenomics, Research, triple-negative breast cancer, vimentin

Unraveling the complexity of cancer biology can lead to the identification new molecules involved in breast cancer and prompt new avenues for drug development. And

Read more
From The Labs 

Mutated genes and rogue proteins can reveal new ways to treat breast cancer

May 10, 2017Breast Cancer, breast tumor, mass spectrometry, personalized treatments, proteogenomics, tumor xenograft

Scientists are puzzled by mysteries such as, why a certain drug that induced one tumor to shrink in one patient did not affect the growth

Read more

From the Labs Image of the Month

From The Labs Image of the Month From the Labs: Adult-born neurons made the cover

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951